What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Ib Jarle Christensen mainly focuses on Internal medicine, Pathology, Cancer, Gastroenterology and Colorectal cancer.
The study incorporates disciplines such as Endocrinology and Oncology in addition to Internal medicine.
His study in Pathology is interdisciplinary in nature, drawing from both Prognostic variable, Primary tumor, Surgical oncology, Ploidy and Tumor lysis syndrome.
His Cancer research is multidisciplinary, incorporating elements of Immunohistochemistry, Biomarker, Melanoma and Enzyme inhibitor.
His Gastroenterology study integrates concerns from other disciplines, such as SuPAR, Metastasis, Univariate analysis, Blood plasma and Survival analysis.
The various areas that he examines in his Colorectal cancer study include Carcinoembryonic antigen, Rectum, Blood transfusion, Immunology and Carcinoma.
His most cited work include:
- A Detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis† (1522 citations)
- Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. (517 citations)
- Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry. (407 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Oncology, Cancer, Colorectal cancer and Pathology.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Endocrinology.
His Oncology research integrates issues from Chemotherapy, Ovarian cancer, Proportional hazards model, Breast cancer and Survival analysis.
His research in Cancer tackles topics such as Cancer research which are related to areas like Plasminogen activator.
His Colorectal cancer research incorporates themes from Carcinoembryonic antigen, Prospective cohort study, Surgery, Immunology and Blood plasma.
His work is dedicated to discovering how Pathology, Flow cytometry are connected with DNA and other disciplines.
He most often published in these fields:
- Internal medicine (62.96%)
- Oncology (37.04%)
- Cancer (30.41%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (62.96%)
- Oncology (37.04%)
- Cancer (30.41%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Oncology, Cancer, Colorectal cancer and Cancer research.
His research on Internal medicine frequently connects to adjacent areas such as Gastroenterology.
His studies deal with areas such as Bioinformatics, Gene expression profiling, Ovarian cancer, Hazard ratio and Breast cancer as well as Oncology.
The Cancer study combines topics in areas such as Urokinase receptor and Biopsy, Pathology.
His study in Colorectal cancer is interdisciplinary in nature, drawing from both Metastasis, Retrospective cohort study and Adenoma.
His research in Cancer research intersects with topics in Methylation, Survival analysis, Immune system and DNA methylation.
Between 2015 and 2021, his most popular works were:
- The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma. (32 citations)
- Relapse and disease specific survival in 1143 Danish women diagnosed with borderline ovarian tumours (BOT) (21 citations)
- Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers. (19 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
The scientist’s investigation covers issues in Internal medicine, Oncology, Colorectal cancer, Cancer and Multivariate analysis.
His research integrates issues of Gastroenterology and Immunology in his study of Internal medicine.
His Oncology study also includes fields such as
- Bevacizumab together with Young adult,
- Irinotecan most often made with reference to Retrospective cohort study,
- Survival rate together with Carcinoma.
His Colorectal cancer study integrates concerns from other disciplines, such as Logistic regression, microRNA and Metastasis.
His biological study spans a wide range of topics, including Urokinase receptor and Observational study, Prospective cohort study, Pathology.
His Multivariate analysis research includes themes of Stage, Gynecology, Cohort study and Population study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
